These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1010180

  • 1. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC, Corgnati A, Palù CD.
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [Abstract] [Full Text] [Related]

  • 2. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD, Hesse CJ.
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F, Braun B, Klaus D, Lemke R, Zehner J.
    Dtsch Med Wochenschr; 1976 Oct 08; 101(41):1482-8. PubMed ID: 183943
    [Abstract] [Full Text] [Related]

  • 4. Propranolol, renin and hypertension: a review.
    Laragh JH, Bühler FR.
    Postgrad Med J; 1976 Oct 08; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Oct 08; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 6. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
    Pessina AC, Corgnati A, Palù CD.
    Minerva Med; 1977 Feb 18; 68(8):509-14. PubMed ID: 846681
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F, Perini A, Armanini D, Gion M, Opocher G, Boscaro M.
    G Ital Cardiol; 1976 Feb 18; 6(7):1246-53. PubMed ID: 1010235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW, Sherman K, Zwagg RV, Shand DG.
    N Engl J Med; 1976 Jul 08; 295(2):68-73. PubMed ID: 775330
    [Abstract] [Full Text] [Related]

  • 13. The effects of propranolol on spontaneous and experimental hypertension in the rat.
    Pessina AC, Corgnati A, Palatini P, Oneglia C, Palu CD.
    Clin Sci Mol Med Suppl; 1976 Dec 08; 3():447s-450s. PubMed ID: 1071662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Behavior of blood volume and electrolytes in patients with essential hypertension with low plasmatic renin activity (PRA). Effects of treatment with propranolol].
    Aguglia F, Santucci A, Cicconetti P, Federico M, Caputo V, Balsano F.
    Boll Soc Ital Cardiol; 1978 Dec 08; 23(8):1340-8. PubMed ID: 398712
    [No Abstract] [Full Text] [Related]

  • 18. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF, Laragh JH.
    Urol Clin North Am; 1975 Jun 08; 2(2):237-57. PubMed ID: 1098253
    [Abstract] [Full Text] [Related]

  • 19. [Effect of obzidan on hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with juvenile hypertension].
    Zanozdra NS, Chernoguz LS, Kupchinskaia SG, Primak GF, Korchinskaia OI.
    Vrach Delo; 1989 Jun 08; (6):41-3. PubMed ID: 2675468
    [Abstract] [Full Text] [Related]

  • 20. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F, Davison AM.
    Clin Nephrol; 1986 Mar 08; 25(3):149-54. PubMed ID: 2869848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.